Efficacy and safety of sunvozertinib in treatment naive NSCLC patients with EGFR exon20 insertion mutations

被引：0
|
作者：
Xu, Yan
Yang, James Chih-Hsin
Chiu, Chao-Hua
Hsu, Ping-Chih
Mitchell, Paul
Chang, Chia Lun
John, Tom
Bazhenova, Lyudmila
Kim, Tae Min
Yip, Ching Wan
Wang, Mengzhao
Janne, Pasi A.
Zhou, Caicun
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ Canc Ctr, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Taipei, Taiwan
[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan
[6] Austin Hosp, Melbourne, Vic, Australia
[7] Wan Fang Hosp, Taipei, Taiwan
[8] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[9] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
[10] Seoul Natl Univ Hosp, Seoul, South Korea
[11] Dizal Pharmaceut, Shanghai, Peoples R China
[12] Dana Farber Canc Inst, Boston, MA 02115 USA
[13] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9073
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
    Ou, Sai-Hong Ignatius
    Lin, Huamao M.
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (10):
  • [22] Efficacy and safety of dacomitinib in treatment-naive patients with advanced NSCLC harboring uncommon EGFR mutations
    Wu, L.
    Pu, X.
    Zhou, Y.
    Kong, Y.
    Chen, B.
    Yang, A.
    Li, J.
    Li, K.
    Xu, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1695 - S1695
  • [23] Resistance mechanisms to mobocertinib in treating NSCLC with EGFR exon 20 insertion mutations
    Le, Xiuning
    Nilsson, Monique
    Chatterjee, Sampurna
    Su, Zhenqiang
    He, Junqin
    Udagawa, Hibiki
    Yu, Xiaoxing
    Poteete, Alissa
    Huang, Qian
    Heymach, John V.
    Vincent, Sylvie
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [24] Preliminary safety and activity of CLN-081 in NSCLC with EGFR exon 20 insertion mutations (Ins20)
    Piotrowska, Z.
    Nguyen, D.
    Koczywas, M.
    Tchekmedyian, N.
    Clancy, M. S.
    Witter, D.
    Page, A.
    Zawel, L.
    Yu, H. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S862 - S863
  • [25] A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
    Yan Chen
    Bo Jiang
    Yuange He
    Chu Zhang
    Wenjie Zhou
    Cheng Fang
    Dejian Gu
    Minxia Zhang
    Mei Ji
    Juntao Shi
    Xin Yang
    BMC Medical Genomics, 15
  • [26] A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
    Chen, Yan
    Jiang, Bo
    He, Yuange
    Zhang, Chu
    Zhou, Wenjie
    Fang, Cheng
    Gu, Dejian
    Zhang, Minxia
    Ji, Mei
    Shi, Juntao
    Yang, Xin
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [27] Phase 1 Studies of DZD9008, an Oral Selective EGFR/HER2 Inhibitor in Advanced NSCLC with EGFR Exon20 Insertion Mutations
    Janne, P.
    Wang, M.
    Mitchell, P.
    Fang, J.
    Nian, W.
    Chiu, C.
    Zhou, J.
    Zhao, Y.
    Su, W.
    Camidge, D. R.
    Yang, T.
    Zhu, V.
    Millward, M.
    Fan, Y.
    Huang, W.
    Cheng, Y.
    Jiang, L.
    Brungs, D.
    Bazhenova, L.
    Lee, C. K.
    Gao, B.
    Qi, S.
    Yu, X.
    Deng, C.
    Chen, K.
    Ye, X.
    Zheng, L.
    Yang, Z.
    Yang, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S874 - S874
  • [28] Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.
    Ou, Sai-Hong Ignatius
    Lin, Huamao Mark
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
    Zhang, Shannon S.
    Zhu, Viola W.
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 61 - 65
  • [30] Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
    Lv, D.
    Lin, L.
    Wu, X.
    Yan, S.
    Ge, H.
    Yan, Z.
    Wang, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S634 - S634
12345